| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Human Cancer Biology |
Authors' Affiliations: Institutes of 1 Tumor Biology, 2 Clinical and Experimental Pharmacology, and 3 Pathology, University Medical Center Hamburg-Eppendorf, and 4 Heinrich Pette Institute for Experimental Virology and Immunology at the University of Hamburg, Hamburg, Germany
Requests for reprints: Klaus Pantel, Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, D-20246, Hamburg, Germany. Phone: 49-404-2803-3503; Fax: 49-404-2803-5379; E-mail: pantel{at}uke.uni-hamburg.de.
Purpose: The bone marrow is a frequent and clinically important homing site for early disseminated breast cancer cells. Here, we aimed to profile the protein expression of these cells using unique cell line models and to evaluate the prognostic relevance of candidate gene expression for breast cancer patients.
Experimental Design: To identify expression patterns characteristic for micrometastatic cells, three different cell lines (BC-K1, BC-P1, and BC-S1) established by SV40 immortalization of cancer cells isolated from the bone marrow of patients with breast cancer were compared with MCF-7 breast cancer and SV40 immortalized normal breast ductal cells (MTSV-1.7) using two-dimensional gel electrophoresis followed by MALDI-ToF analysis. The prognostic significance and clinicopathologic associations of selected differentially expressed proteins were evaluated using high-density breast cancer tissue microarrays.
Results: In contrast to MCF-7 and MTSV1-7 reference cell lines, all micrometastatic cancer cell lines displayed loss of epithelial cytokeratins (CK8, CK18, and CK19) and ectopic expression of vimentin commonly present in mesenchymal cells. Immunohistochemical analysis of 2,517 samples of breast cancer further showed that loss of cytokeratin and ectopic vimentin expression were significantly associated with a higher tumor grade, high mitotic index, and negative estrogen/progesterone-receptor status. Although in univariate analyses significantly related to clinical outcome, none of the cytokeratins analyzed were independently associated with either overall or cancer-specific survival.
Conclusions: Micrometastatic cancer cells exhibit marked changes in the expression pattern of cytoskeletal proteins indicative of an epithelial-mesenchymal transition. This phenotypical change could already be detected in primary tumors and is associated with the aggressive behavior of breast cancer cells in vivo.
This article has been cited by other articles:
|
|
 |
|
  G. Pampalakis, E. Prosnikli, T. Agalioti, A. Vlahou, V. Zoumpourlis, and G. Sotiropoulou A Tumor-Protective Role for Human Kallikrein-Related Peptidase 6 in Breast Cancer Mediated by Inhibition of Epithelial-to-Mesenchymal Transition Cancer Res., May 1, 2009; 69(9): 3779 - 3787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Massard, A. Chauchereau, and K. Fizazi The quest for the 'bony Grail' of detecting circulating tumour cells in patients with prostate cancer Ann. Onc., February 1, 2009; 20(2): 197 - 199. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Sun, S. Zhang, D. Zhang, Y. Li, X. Zhao, Y. Luo, and Y. Guo Identification of Metastasis-Related Proteins and Their Clinical Relevance to Triple-Negative Human Breast Cancer Clin. Cancer Res., November 1, 2008; 14(21): 7050 - 7059. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Blick, E. Widodo, H. Hugo, A. Fabra-Fres, R. Wafai, D. Gunasinghe, M. Waltham, M. Lenburg, R. Neve, D. Newgreen, et al. Abstract CN12-03: Epithelial-mesenchymal transition in human breast cancer progression: cancer stem cell attributes, dissemination, and dormancy Cancer Prevention Research, November 1, 2008; 1(7_MeetingAbstracts): CN12-03 - CN12-03.
|
|
|
|
 |
|
 R. J. Paccione, H. Miyazaki, V. Patel, A. Waseem, J. S. Gutkind, Z. E. Zehner, and W. A. Yeudall Keratin down-regulation in vimentin-positive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motility Mol. Cancer Ther., September 1, 2008; 7(9): 2894 - 2903. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Alix-Panabieres, S. Riethdorf, and K. Pantel Circulating Tumor Cells and Bone Marrow Micrometastasis Clin. Cancer Res., August 15, 2008; 14(16): 5013 - 5021. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Whipple, E. M. Balzer, E. H. Cho, M. A. Matrone, J. R. Yoon, and S. S. Martin Vimentin Filaments Support Extension of Tubulin-Based Microtentacles in Detached Breast Tumor Cells Cancer Res., July 15, 2008; 68(14): 5678 - 5688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Vincent-Salomon, F C Bidard, and J Y Pierga Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues J. Clin. Pathol., May 1, 2008; 61(5): 570 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Pantel, C. Alix-Panabieres, and S. Riethdorf Circulating Tumor Cells: Detection and Clinical Relevance Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 603 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Huang, S. V. Fernandez, S. Goodwin, P. A. Russo, I. H. Russo, T. R. Sutter, and J. Russo Epithelial to Mesenchymal Transition in Human Breast Epithelial Cells Transformed by 17 -Estradiol Cancer Res., December 1, 2007; 67(23): 11147 - 11157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chu, H. Xu, T. J. Ferro, and P. X. Rivera Poly(ADP-ribose) polymerase-1 regulates vimentin expression in lung cancer cells Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1127 - L1134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Rodriguez-Pinilla, D. Sarrio, E. Honrado, G. Moreno-Bueno, D. Hardisson, F. Calero, J. Benitez, and J. Palacios Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas J. Clin. Pathol., September 1, 2007; 60(9): 1006 - 1012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Baumgart, M. S. Cohen, B. S. Neto, M. A. Jacobs, C. Wotkowicz, K. M. Rieger-Christ, A. Biolo, R. Zeheb, M. Loda, J. A. Libertino, et al. Identification and Prognostic Significance of an Epithelial-Mesenchymal Transition Expression Profile in Human Bladder Tumors Clin. Cancer Res., March 15, 2007; 13(6): 1685 - 1694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Riethdorf, H. Fritsche, V. Muller, T. Rau, C. Schindlbeck, B. Rack, W. Janni, C. Coith, K. Beck, F. Janicke, et al. Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System Clin. Cancer Res., February 1, 2007; 13(3): 920 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Lee, S. Dedhar, R. Kalluri, and E. W. Thompson The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol., March 27, 2006; 172(7): 973 - 981. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
